ABOUT US
Company Overview
Leadership
History
Contact Us
mRNA PLATFORM
TECHNOLOGY
CAPPING TECHNOLOGY
MODIFIED NUCLEOSIDE
3’END MODIFICATION
CAP ANALOGS
(ORDER)
MS₁Cap
MS₂Cap
MS₃Cap
MS₄Cap
PIPELINE
Cancer immunotherapy
mRNA vaccine for infectious diseases
CUSTOMER
SUPPORT
Quotation & Product Inquiry
FAQ
NEWSROOM
Notice
News
Media
Title
Content
NO.
Title
Writer
Date
1
Homepage
관리자
2025.12.30
1
